6 research outputs found
Performance of Croatina under short-cane mechanical hedging: A successful case of adaptation
The hypothesis that short mechanical hedging can be successfully applied even on cultivars with low fruitfulness of basal buds was tested over four years (2000 to 2003) on Vitis vinifera L. cv. Croatina. Yield per vine increased from 23 to 49% on hedged vines as compared to short-cane hand-pruned vines; up to a 30% increase (equivalent to 3c60 nodes per vine) there was no detriment to grape quality, and labor demand was cut by 55 to 60%. Yield compensation in the hedged vines mostly occurred as reduced budbreak; weak or no compensation effects were seen for cluster weight and bud fruitfulness, respectively. A tendency for impaired quality was seen only at the highest node number per vine ( 3c75), while the linear relationship found between yield and node number per vine suggests that short-cane hand-pruning can also be feasible provided that at least 30 nodes per meter of row are retained. These findings indicate that mechanical pruning can be an excellent tool for converting traditionally long-cane pruned cultivars into short-cane pruned with related advantages in terms of more balanced growth and ripening and adaptability to full mechanization
Antioxidants Partially Restore Glutamate Transport Defect in Leber Hereditary Optic Neuropathy Cybrids
Leber hereditary optic neuropathy (LHON) is a mitochondrial disease characterized by visual loss resulting from retinal ganglion cell degeneration. Despite the important role of respiratory chain deficiency and oxidative stress induced by mtDNA point mutations affecting complex I, excitotoxic injury has been postulated as a concurrent pathogenic factor. We used transmitochondrial cybrid cell lines constructed using enucleated fibroblasts from three LHON probands carrying the most severe 3460/ND1 mutation and three controls as mitochondria donors, and the osteosarcoma-derived mtDNA-less cells, to study the possible efficacy of two selected antioxidant compounds in preventing glutamate uptake reduction previously observed in LHON cybrids. We demonstrated that two antioxidants, Trolox and decylubiquinone, partially restore glutamate transport impairment occurring in LHON cybrids. Rotenone, a classic complex I inhibitor, did not worsen the glutamate uptake defect present in LHON cybrids under basal conditions but significantly reduced glutamate transport in control cybrids. Furthermore, we observed that LHON cybrids showed an increased protein carbonylation under basal conditions, not further affected by rotenone and partially counteracted by antioxidants. Our findings strengthen the hypothesis that the complex I defect associated with LHON causes free radical overproduction, which is responsible for glutamate transport inhibition. We suggest that selected antioxidants may be clinically tested in LHON patients and relatives to restore glutamate uptake defect caused by LHON-associated free radical overproduction
Economic implications of water efficiency measures II: cost-effectiveness of composite strategies
Economic implications of water efficiency measures I: assessment methodology and cost-effectiveness of micro-components
PREAMI: Perindopril and remodelling in elderly with acute myocardial infarction: Study rationale and design
PREAMI: Perindopril and remodelling in elderly with acute myocardial infarction: Study rationale and design
Angiotensin-converting enzyme (ACE) inhibitors reduce mortality, the development of remodeling, left ventricular (LV) dysfunction, and ischemic events, both when administered alone as long-term treatment in patients with impaired LV function and/or heart failure (HF) and as short-term treatment, early after acute myocardial infarction (AMI) and/or HF. The few data available on the use of ACE inhibitors in the elderly after AMI are conflicting. Nothing is known about the effects of ACE inhibitors in elderly postinfarction patients with preserved LV function: these patients have a remarkable medium- to long-term mortality and HF incidence after infarction. The aim of this study is to evaluate, in patients with AMI aged ≥65 years, the effects of Perindopril on the combined outcome of death, hospitalization for HF, and heart remodeling, considered to be a ≥8% increase in LV end-diastolic volume (LVEDV). Secondary objectives include the same factors listed in the primary end points hut considered separately. In addition, safety of the drug, ventricular remodeling, and adaptation are being evaluated. A total of 1100 patients with AMI (first episode or reinfarction), aged ≥65 years, and preserved or only moderately depressed LV (LV ejection fraction ≥40%), are to he enrolled and randomly assigned to treatment (8 mg for 12 months of Perindopril or placebo, in double-blind conditions). Clinical assessment is performed at fixed times, and periodic evaluations of (1) ventricular shape, dimensions, and function by quantitative 2-D echocardiography, and (2) heart rate variability and arrhythmias by ambulatory electrocardiographic monitoring are anticipated. The results and conclusions will be available by 2002 year